Primary hyperparathyroidism and malignancy: "studies by nature".

  title={Primary hyperparathyroidism and malignancy: "studies by nature".},
  author={Udi Cinamon and Robert E Turcotte},
  volume={39 2},
The American Food and Drug Administration approval of parathyroid hormone (PTH) administration for osteoporosis as well as the possibility for its future therapeutic applications requires an examination of the suggested association between PTH and cancer, particularly osteosarcomas. The objective was to evaluate such a connection by collecting observational data from two groups of patients, designated as "studies by nature". Cohort 1: Medical records of all patients with primary… CONTINUE READING